- Generated second quarter 2021 total revenue of $12.5 million, an increase of 258% compared to the prior year period, including;
- Surgical Glaucoma sales of $12.0 million, an increase of 263% compared to the prior year period
- Dry Eye sales of $0.5 million, an increase of 169% compared to the prior year period
- Expanded gross margin to 82% in the second quarter 2021 versus 40% in the prior year period
- Completed an initial public offering in July raising approximately $253 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses
Zhongchao Inc. Establishes Zhixun Internet Hospital To Provide Patient With Management Services Focusing On The Oncology And Other Major Diseases
Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational